Jacques Aj Malherbe

11PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Respiratory diseasesOptical technologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 29, 2025
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML.

Rithin Nedumannil, Michael Ashby, James Rowland

|Jun 25, 2025
Megakaryocyte emperipolesis in myeloproliferative neoplasms: Are neutrophils friends or foes?

Ryan J Collinson, Matthew D Linden, Kathryn A Fuller

|Apr 26, 2025
Diagnostic and Therapeutic Challenges in an Acute Variegate Porphyric Crisis Complicated by Anuric Renal Failure and Multiorgan Dysfunction: A Case Report.

Peter B Conroy, Sue Davel, Jacques A J Malherbe

|Apr 04, 2024
COVID-19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy.

Jacques A J Malherbe, Peter Boan, Duncan Purtill

|Nov 18, 2022
A complex case of necrobiotic xanthogranuloma with IgG-kappa paraproteinemia: Disease regression achieved with melphalan and prednisone combination therapy.

Jacques A J Malherbe, Julian Cooney

|Oct 18, 2022
Double trouble: A case of fraternal twins with iron-refractory iron-deficiency anemia.

Jacques A J Malherbe, Catherine H Cole

Pageof 2

Frequent Collaborators

2 joint publications

Belinda B Guo

2 joint publications

Wendy N Erber

1 joint publications

Katie Meehan

1 joint publications

Peter Boan